Literature DB >> 971460

Ten cases of malignant hyperthermia in Norway.

J Stovner, K R Innes, A Holen.   

Abstract

Data are presented on ten cases of anaesthesia-induced malignant hyperthermia in Norway. Seven of the patients died, three recovered. The fatal cases were all boys in the age group 11-20 years. This age and sex distribution suggests that puberty with the increase in androgens is a precipitating factor in malignant hyperthermia. One of the victims who survived was a 4 1/2-year-old pseudohermaphrodite girl with the adrenogenital syndrome. The coincidence of malignant hyperthermia in a patient with such a rare syndrome points to the excessive formation of androgens in patients with this syndrome as a predisposing factor. The indications for surgery were traumatic injuries in five cases, congenital abnormalities in three and appendicitis in two cases. These conditions in themselves may cause an increased sensitivity to suxamethonium. One patient received only hexobarbitone, halothane and suxamethonium. After the last drug jaw rigidity and temperature rise to 41.3 degrees C prompted the anaesthetist to end the anaesthetic. The fact that the patient survived proves that suxamethonium induced jaw rigidity is valuable as a warning. The absence of cardiovascular depression after procaine 3.5 g in one patient is ascribed to the correction of acidosis at the time of infusion of this drug. It is suggested that procaine should be withheld until other measures such as cooling, correction of acidosis and steroid therapy have been tried.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971460     DOI: 10.1007/BF03005980

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  21 in total

1.  An evaluation of procaine in the treatment of malignant hyperpyrexia.

Authors:  I M Clarke; F R Ellis
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

2.  Anaesthesia during raised creatine phosphokinase activity.

Authors:  G Owen; R J Kerry
Journal:  Br Med J       Date:  1974-10-12

3.  Drugs causing rigidity in malignant hyperthermia.

Authors:  W Kalow; B A Britt
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

4.  Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.

Authors:  B A Britt
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

5.  Procainamide therapy of malignant hyperthermia: case report.

Authors:  J Brebner; J A Jozefowicz
Journal:  Can Anaesth Soc J       Date:  1974-01

6.  Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man.

Authors:  H D Weintraub; D V Heisterkamp; L H Cooperman
Journal:  Br J Anaesth       Date:  1969-12       Impact factor: 9.166

7.  Changes in serum potassium response to succinylcholine following trauma.

Authors:  A A Birch; G D Mitchell; G A Playford; C A Lang
Journal:  JAMA       Date:  1969-10-20       Impact factor: 56.272

8.  Hereditary aspects of malignant hyperthermia.

Authors:  B A Britt; W G Locher; W Kalow
Journal:  Can Anaesth Soc J       Date:  1969-03

9.  [Malignant hyperpyrexia--a serious anaesthetic complication].

Authors:  H Gjengstö
Journal:  Anaesthesist       Date:  1971-08       Impact factor: 1.041

10.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

View more
  2 in total

1.  Masseter contracture and tachycardia causing termination of anesthesia.

Authors:  B W Burger; E Malsch; B W Mayer
Journal:  Anesth Prog       Date:  1984 Nov-Dec

2.  Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report.

Authors:  R Melvoll; J Stovner; M Whittaker
Journal:  Can Anaesth Soc J       Date:  1980-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.